Brain anatomy may influence blood flow regulation
NCT ID NCT05396287
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study investigates how natural variations in brain anatomy affect the brain's ability to regulate blood flow. Healthy adults undergo an MRI while performing two breathing tests—one with increased carbon dioxide and one with low oxygen—to measure changes in brain blood flow. The goal is to compare responses between people with and without a specific anatomical variation (VAH). This research may help scientists better understand individual differences in brain blood flow regulation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could improve understanding of how brain anatomy affects blood flow regulation, potentially guiding future research on brain health.
- What could go wrong
- This is an observational study with no treatment, so it will not directly improve health. Results may not apply to people with medical conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2022
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Subjects for this study, will include healthy adults enrolled in the Wisconsin Alzheimer's Disease Research Clinical Core. Both men and women are eligible to participate in this study.
- Ages
-
55 to 69 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BMI ≤38.5 kg/m2 * Nonsmoker * Female subjects: postmenopausal * Currently enrolled in the Wisconsin Alzheimer's Disease Research Clinical Core Exclusion Criteria: * Diagnosis of mild cognitive impairment or Alzheimer's disease * Uncontrolled hypertension * History or evidence of hepatic disease, hematological disease, or peripheral vascular disease * Severe kidney injury requiring hemodialysis * Cardiovascular disease including: severe congestive heart failure, coronary artery disease, ischemic heart disease (stents, coronary artery bypass grafts) and tachycardia * History of clinically significant ischemic or hemorrhagic stroke, or significant cerebrovascular disease * History of HIV/AIDS * Severe untreated obstructive sleep apnea * History of diabetes with HbA1c greater than 9.5% * Major neurologic disorders other than dementia (e.g., multiple sclerosis, amyotrophic lateral sclerosis, brain surgery, etc.) * Current or recent (\<1 year) major psychiatric condition (Axis I) or addictive disorders * Contraindications to MRI
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brain blood flow are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin-Madison
Madison, Wisconsin, 53706, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The effects of external nasal dilator strips on sleep and cardiovascular health
- A pharmacokinetic study of NTI164 in healthy adult volunteers
- Genetic determinants of Exercise-Induced muscle damage (POLYGENDOMUS) / déterminants génétiques des dommages musculaires induits par l'Exercice (POLYGENDOMUS)
- Can a simple injection timing reduce bleeding after skin cancer surgery?
- Can Land-Based teachings shape psychedelic therapy training?
- Can a new oral drug pass early safety tests?